Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia
Abstract
Importance
New antibacterials are needed to treat community-acquired bacterial pneumonia (CABP) because of growing antibacterial resistance and safety concerns with standard care.Objective
To evaluate the efficacy and adverse events of a 5-day oral lefamulin regimen in patients with CABP.Design, Setting, and Participants
A phase 3, noninferiority randomized clinical trial conducted at 99 sites in 19 countries that...Paper Details
Title
Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia
Published Date
Nov 5, 2019
Journal
Volume
322
Issue
17
Pages
1661 - 1661
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History